Based on recent data, Aura Biosciences, Inc. (AURA) shows an Average True Range (ATR) of 0.37 and an Enterprise Value of 329.96M. Its average trading volume over the past 3 months is 555.05K, indicating liquidity. These fundamental metrics provide insight into AURA's underlying financial health and market activity.
| ATR | 0.37 |
| Enterprise Value | 329.96M |
| Avg Vol (3 Months) | 555.05K |
| Avg Vol (10 Days) | 363.16K |
Aura Biosciences, Inc. (AURA) technical indicators as of August 6, 2026: the SMA 20 is 6.87%, SMA 50 at 7.75%, and SMA 200 at -1.41%. The RSI 14 value is 59.46, suggesting its current momentum. These technical analysis signals help assess AURA's price trends and potential future movements.
| SMA 20 | 6.87% |
| SMA 50 | 7.75% |
| SMA 200 | -1.41% |
| RSI 14 | 59.46 |
Aura Biosciences, Inc. (AURA) stock performance overview as of August 6, 2026: The 52-week high is $9.54 (currently -22.64% below), and the 52-week low is $4.73 (currently 37.63% above). Over the past year, AURA's performance is -35.2%, compared to the S&P 500's 4.09% change.
| 52-Week High | 9.54 |
| 52-Week High Chg | -22.64% |
| 52-Week Low | 4.73 |
| 52-Week Low Chg | +37.63% |
| S&P 500 52-Week Chg | 4.09% |
According to market data, Aura Biosciences, Inc. (AURA) stock's recent performance metrics show that over the last month, AURA is -15.04%, with a Year-to-Date (YTD) performance of -8.81%. Over the past year, the stock has seen a -35.2% change. These figures summarize AURA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 7.74 | 7.74 | 8.96 | 9.54 | 9.54 | 9.54 |
| Low | 6.8 | 6.55 | 6.03 | 4.87 | 4.73 | 4.73 |
| Performance | -1.97% | -15.04% | -12.35% | -26.59% | -35.20% | -8.81% |
According to current financial data, AURA stock's P/E (TTM) ratio is -4.24, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for AURA, including P/S (N/A), P/B (4.72), and P/FCF (-5.26), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AURA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -4.24 | -1.24 | -193.07 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.88 | 5.98 |
| P/B (TTM) | 4.72 | 0.68 | -3445.17 | 5.6 |
| P/FCF (TTM) | -5.26 | -0.03 | -645.86 | 31.69 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep